To view the PDF file, sign up for a MySharenet subscription.

ASCENDIS HEALTH LIMITED - Appointment of Chief Executive Officer and Executive Director

Release Date: 02/09/2019 07:45
Code(s): ASC     PDF:  
 
Wrap Text
Appointment of Chief Executive Officer and Executive Director

Ascendis Health Limited
(Registration number 2008/005856/06)
(Incorporated in the Republic of South Africa)
Share code: ASC
ISIN: ZAE000185005
(“Ascendis Health”)

APPOINTMENT OF CHIEF EXECUTIVE OFFICER AND EXECUTIVE DIRECTOR

The board of directors of Ascendis Health (“the Board”) is pleased to announce the
appointment of Mark Sardi as Chief Executive Officer (“CEO”) and an executive director with
effect from 14 October 2019.

Ascendis Health chairman Andrew Marshall said: “Mark has extensive experience in senior
leadership positions in investment banking, the pharmaceutical industry and the retail sector,
with a strong track record in strategic, operational and financial management in large listed
and unlisted companies. He has demonstrated his leadership ability in turning around complex
organisations and is experienced in operating in international, multi-cultural business
environments. Mark is well equipped to lead Ascendis Health where the priorities are to turn
around under-performing businesses, dispose of non-core assets, reduce gearing and
improve cash management while capitalising on the strong brand portfolio to generate organic
sales growth. The Board welcomes Mark and looks forward to benefiting from his vast
experience and proven leadership skills.”

Background information on Mark Sardi
After qualifying as a chartered accountant Mark spent his early career in corporate finance
and investment banking in London and Johannesburg and served as managing director and
joint head of investment banking at Nedbank Capital for five years. He joined Truworths
International as chief financial officer in 2010 with responsibility for finance, governance,
African expansion, business development and investor relations. Three years later he was
appointed as deputy CEO of generic pharmaceutical business Cipla South Africa where he
was responsible for strategy, M&A and human resources. In 2014 Mark was appointed as
group CEO of House of Busby, the master franchisor for leading international apparel brands.

2 September 2019
Johannesburg


Sponsor
Questco Corporate Advisory Proprietary Limited

Date: 02/09/2019 07:45:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.

Email this JSE Sens Item to a Friend.

Share This Story